People channel feed – Endpoints News

People channel feed

Eliem CEO exits as neuro upstart chops headcount, pivots to preclinical program

3 years ago

Thermo Fisher shrinks headcount in San Diego area, axing over 200 positions

3 years ago

Aligos cuts another 10% of its workforce in reprioritization for NASH and Covid pipelines

3 years ago

Magenta CEO exits, 84% of staff let go as shuttering looms

3 years ago

Exclusive: Verily welcomes Atara Biotherapeutics veteran as new CFO

3 years ago

Bayer taps Roche's Bill Anderson to lead pharma giant as CEO

3 years ago

Ovid brings two Big Pharma vets on board as new CMO, head of epilepsy research

3 years ago

Merck-Novartis revolving door spins again as AI leader Iya Khalil switches pharmas

3 years ago

Updated: Biden's science team sees another mini-transition as Alondra Nelson departs

3 years ago

Epilepsy and Alzheimer's cell therapy biotech lays off 25% of staff

3 years ago

Astellas taps chief strategy officer as next CEO to 'go on the aggressive'

3 years ago

Neurodegenerative biotech Vyant warns of potential wind-down

3 years ago

Canadian plant-based vaccine developer Medicago shutters months after layoffs

3 years ago

J&J’s Janssen lays off employees at Pennsylvania, New Jersey sites

3 years ago

Parthenon Therapeutics CEO exits weeks after co-founder leaves

3 years ago

Incoming Roche CEO builds out his top team, tapping Genentech vet to lead pharma division

3 years ago

KKR healthcare vet Jim Momtazee’s investment firm closes $3.9B inaugural fund

3 years ago

Simba Gill staying on at Evelo to weather layoffs and a PhII fail

3 years ago

'Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end

3 years ago

Cell therapy biotech shifts focus to UK, makes deep cuts to US headcount

3 years ago

New competitors push Sanofi to offer voluntary retirement packages at two Indian sites

3 years ago

Amid application tsunami, FDA's top cell and gene therapy leader to retire in March

3 years ago

Inovio’s decades of shifting extends to wayward winter in pipeline, workforce thinning

3 years ago

After pivoting from Alzheimer's to bone conditions, biotech pivots again — and halves its headcount

3 years ago

First page Previous page 32 33 343536 37 38 Next page Last page